M Lazzarino Selected Research

M Lazzarino Research Topics

Disease

10	Multiple Myeloma 07/2008 - 04/2001
8	Neoplasms (Cancer) 02/2012 - 06/2000
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2008 - 06/2000
4	Lymphoma (Lymphomas) 02/2007 - 02/2001
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2004 - 06/2000
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2002 - 10/2000
2	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2007 - 09/2001
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2004 - 01/2002
2	Leukemia 09/2001 - 10/2000
1	Hematologic Neoplasms (Hematological Malignancy) 02/2012
1	Second Primary Neoplasms (Neoplasms, Second) 02/2012
1	Polycythemia (Erythrocytosis) 02/2009
1	Plasmacytoma 05/2008
1	Papilloma (Papillomatosis) 07/2007
1	Infections 07/2007
1	Osteonecrosis (Kienbock's Disease) 07/2007
1	Bronchiolitis Obliterans Syndrome 07/2007
1	Vomiting 12/2004
1	Nausea 12/2004
1	Immunoglobulin Light-chain Amyloidosis 09/2004
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2004
1	Thrombosis (Thrombus) 09/2004
1	Paraproteinemias (Monoclonal Gammopathy) 09/2004
1	Proteinuria 09/2004
1	Neutropenia 09/2004
1	Lymphocytosis 09/2004
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2004
1	Pathologic Complete Response 01/2004
1	Disease Progression 12/2003
1	Sarcoma (Soft Tissue Sarcoma) 12/2003
1	Carcinogenesis 12/2003
1	Essential Thrombocythemia 10/2002
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2002
1	Bone Resorption 04/2001
1	Bone Diseases (Bone Disease) 04/2001
1	Hodgkin Disease (Hodgkin's Disease) 10/2000
1	Sepsis (Septicemia) 10/2000
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2000
1	Primary Myelofibrosis (Myelosclerosis) 10/2000
1	Acute Myelomonocytic Leukemia 10/2000
1	Polycythemia Vera 10/2000

Drug/Important Bio-Agent (IBA)

4	Dexamethasone (Maxidex)FDA LinkGeneric 07/2008 - 11/2001
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2005 - 10/2000
3	fludarabineIBA 12/2004 - 10/2000
3	Rituximab (Mabthera)FDA Link 07/2004 - 06/2000
2	Thalidomide (Thalomid)FDA Link 07/2008 - 09/2004
2	Etoposide (VP 16)FDA LinkGeneric 12/2005 - 11/2001
2	Cisplatin (Platino)FDA LinkGeneric 12/2005 - 11/2001
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 12/2004 - 09/2001
2	Proteins (Proteins, Gene)FDA Link 08/2003 - 05/2002
2	Pipobroman (Vercyte)FDA Link 10/2002 - 10/2000
1	Dihydrotachysterol (AT 10)IBA 02/2012
1	Erythropoietin FDA Link 02/2009
1	Oxygen (Dioxygen)IBA 02/2009
1	2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA 02/2009
1	Melphalan (Alkeran)FDA LinkGeneric 07/2008
1	Bortezomib (Velcade)FDA Link 05/2008
1	Diphosphonates (Bisphosphonates)IBA 07/2007
1	Zoledronic Acid (Zometa)FDA Link 07/2007
1	Antiviral Agents (Antivirals)IBA 02/2007
1	Amylases FDA Link 12/2004
1	cyclo(Arg-Pro) (CI 4)IBA 09/2004
1	Immunoglobulin M (IgM)IBA 09/2004
1	OsteoprotegerinIBA 09/2004
1	ThrombomodulinIBA 09/2004
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2004
1	Oncogene Proteins (Oncogene Protein)IBA 12/2003
1	Keratins (Keratin)IBA 12/2003
1	AlbuminsIBA 08/2003
1	Immunoglobulin G (IgG)IBA 08/2003
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 08/2003
1	alpha-1-microglobulinIBA 08/2003
1	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2002
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2001
1	Methotrexate (Mexate)FDA LinkGeneric 09/2001
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2001
1	Biomarkers (Surrogate Marker)IBA 04/2001
1	OsteocalcinIBA 04/2001
1	Alkaline PhosphataseIBA 04/2001
1	purineIBA 10/2000
1	Chlorambucil (Leukeran)FDA Link 10/2000
1	Alkylating AgentsIBA 10/2000
1	CD20 AntigensIBA 06/2000
1	Monoclonal AntibodiesIBA 06/2000

Therapy/Procedure

9	Therapeutics 02/2012 - 06/2000
7	Drug Therapy (Chemotherapy) 09/2004 - 06/2000
2	Stem Cell Transplantation 07/2007 - 12/2004
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2007
1	Hematopoietic Stem Cell Mobilization 12/2005
1	Radiotherapy 01/2004
1	Immunotherapy 01/2002
1	Transplantation 05/2001
1	Salvage Therapy 02/2001
1	Combined Modality Therapy 10/2000
1	Adjuvant Radiotherapy 10/2000
1	Laparotomy 10/2000
1	Induction Chemotherapy 10/2000
1	Aftercare (After-Treatment) 10/2000